Monday, November 8, 2010

OncoGenex Pharmaceuticals Names CFO

Bothell-based OncoGenex Pharmaceuticals said this morning that it has named Michelle Burris as Executive Vice President, Operations, and Chief Financial Officers. Burris is currently a member of the firm's board, and previously served at SVP and COO for Trubion Pharmaceuticals. She has also served at The Boeing Company and Cypress International. OncoGenex is a developer of cancer treatments.